Phase 2a Randomized Placebo-Controlled Human Challenge Trial of the RSV L-Protein Inhibitor S-337395 for Respiratory Syncytial Virus Infection

Journal:
Clinical Infectious Diseases
Published:
DOI:
10.1093/cid/ciag367
Affiliations:
4
Authors:
10
Go to article
Institutions Authors Share
Shionogi, Japan
6.000000
 0.60
hVIVO Services Limited, United Kingdom (UK)
3.000000
 0.30
Shionogi - UK, United Kingdom (UK)
1.000000
 0.10